Atlas Trials

Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

Clinical trial NCT00632333 · UNKNOWN

Trial details

NCT number
NCT00632333
Sponsor
Teikyo University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2008-02-01
Primary completion
2011-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.